Crozet BioPharma (United States)

Recent papers from Crozet BioPharma (United States)

1. In Vivo Characterization and Tissue Tropism of a Wild-Type Yellow Fever Virus Isolate from the 2017–2018 Brazilian Outbreak in C57BL/6 IFNAR1−/− MiceViruses · 2025
2. Risk factors associated with in-hospital mortality during yellow fever outbreak in BrazilFrontiers in Medicine · 2025
3. Minimal Protective Antibody Titers Elicited in Sheep by RVFV MP-12 and arMP-12ΔNSm21/384 Vaccine CandidatesInternational Journal of Veterinary Science and Research · 2024
4. Sofosbuvir Off-label Treatment of Yellow Fever Patients During an Outbreak in Brazil, 2018: A Cohort StudyOpen Forum Infectious Diseases · 2024
5. Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017–2018 sylvatic outbreak in BrazilMicrobiology Spectrum · 2024
6. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus diseaseFrontiers in Immunology · 2023
7. Characterization and Investigation of Risk Factors for Late-Relapsing Hepatitis After Yellow FeverClinical Infectious Diseases · 2023
8. Yellow fever resurgence: An avoidable crisis?npj Vaccines · 2022
9. Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of DiseaseAmerican Journal of Tropical Medicine and Hygiene · 2022
10. Single and 2-dose vaccinations with MVA-BN ® induce durable B cell memory responses in healthy volunteers that are comparable to older generation replicating smallpox vaccines2022
11. Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human TrialsJournal of Fungi · 2022
12. Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potentialPLoS Pathogens · 2022
13. Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trialThe Lancet · 2021
14. The Origin of COVID-19 and Why It MattersAmerican Journal of Tropical Medicine and Hygiene · 2020
15. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccinesVaccine · 2020
16. A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human CytomegalovirusThe Journal of Infectious Diseases · 2020
17. Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein VaccineAmerican Journal of Tropical Medicine and Hygiene · 2019